# Dyne Therapeutics, Inc. (DYN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DYN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -299.41M | $ -276.94M | N/A | $ 702.15M |
| 2025 | $ 0 | $ -456.88M | $ -434.05M | N/A | $ 972.13M |
| 2024 | $ 0 | $ -333.63M | $ -309.80M | $ 23.99M | $ 629.84M |
| 2023 | $ 0 | $ -255.11M | $ -204.23M | $ 27.42M | $ 91.29M |
| 2022 | $ 0 | $ -187.78M | $ -175.06M | $ 30.48M | $ 252.36M |
| 2021 | $ 0 | $ -177.46M | $ -146.42M | $ 32.64M | $ 368.20M |
| 2020 | $ 0 | $ -75.72M | $ -60.73M | N/A | $ 342.37M |
| 2019 | $ 0 | $ -19.18M | $ -17.40M | $ 0 | $ 14.04M |
| 2017 | $ 1.36B | $ -1.67B | $ 486.32M | $ 8.43B | $ 1.90B |
| 2016 | $ 1.88B | $ -1.71B | $ 481.54M | $ 8.98B | $ 2.04B |
| 2015 | $ 4.35B | $ 70.20M | $ -254.13M | $ 7.29B | $ 2.92B |
| 2014 | $ 4.75B | $ -87.61M | $ -87.61M | $ 7.11B | $ 3.02B |
| 2013 | $ 1.52B | $ -506.32M | $ 109.51M | $ 1.99B | $ 2.21B |
| 2012 | $ 2.16B | $ 125.61M | $ 0 | $ 1.42B | $ 2.50B |
| 2011 | $ 2.33B | $ -2.42B | $ -384.92M | $ 588.00M | $ 1.11B |
| 2010 | $ 3.52B | $ -354.31M | $ 825.61M | $ 4.57B | $ 2.75B |
| 2009 | $ 3.74B | $ -1.91B | $ 204.41M | $ 1.61B | $ 2.90B |
| 2008 | $ 5.37B | $ 263.46M | $ 483.01M | $ 128.00M | $ 4.52B |
| 2007 | $ 3.83B | $ 378.54M | $ 449.70M | $ 102.00M | $ 4.51B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.42 |
| Current Ratio | 12.02 |

## Other views

- [Metrics](https://sponda.capital/en/DYN.md)
- [Charts](https://sponda.capital/en/DYN/charts.md)
- [Compare](https://sponda.capital/en/DYN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.